Viewing Study NCT02975895


Ignite Creation Date: 2025-12-24 @ 1:12 PM
Ignite Modification Date: 2026-02-24 @ 3:13 PM
Study NCT ID: NCT02975895
Status: COMPLETED
Last Update Posted: 2023-08-30
First Post: 2016-11-15
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Outcome of Different IOLs in Patients With and Without Uveitis
Sponsor: Vastra Gotaland Region
Organization:

Study Overview

Official Title: Outcome With Hydrophobic and Hydrophilic Intraocular Lens in Patients With and Without Uveitis
Status: COMPLETED
Status Verified Date: 2023-08
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Cataract, is a clouding of the lens in the eye gradually leading to reduction of the visual acuity. In most cases it can be managed with surgery, removing the own lens and replacing it with an artificial lens, intraocular lens (IOL). These lenses are made in different materials with different properties.

Uveitis refers to an inflammation in the iris, ciliary body and choroid. Patients with this disease have an increased risk of developing cataract due to the inflammation itself and treatment with steroids. They also have an increased risk of complications during surgery and postoperatively. In this group the selection of IOL might be of greater importance.

The aim of this prospective randomized controlled study is to compare the outcome of hydrophobic and hydrophilic intraocular lenses in patients with and without uveitis
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: